Advanced

Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.

Wadbo, Monika LU ; Löfdahl, Claes-Göran LU ; Larsson, K; Skoogh, B E; Tornling, G; Arweström, E; Bengtsson, T and Ström, K (2002) In European Respiratory Journal1988-01-01+01:00 20(5). p.1138-1146
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Cholinergic Antagonists: adverse effects, Carbon Dioxide: blood, Chronic Obstructive: physiopathology, Quality of Life, Vital Capacity, Walking, Chronic Obstructive: drug therapy, Pulmonary Disease, Adrenergic beta-Agonists: adverse effects, Adrenergic beta-Agonists: therapeutic use, Adult, Aged, Bronchodilator Agents: adverse effects, Bronchodilator Agents: therapeutic use, Cholinergic Antagonists: therapeutic use, Comparative Study, Double-Blind Method, Dyspnea: etiology, Ethanolamines: adverse effects, Ethanolamines: therapeutic use, Female, Forced Expiratory Volume, Human, Ipratropium: adverse effects, Ipratropium: therapeutic use, Male, Middle Age, Oxygen: blood, Physical Endurance
in
European Respiratory Journal1988-01-01+01:00
volume
20
issue
5
pages
1138 - 1146
publisher
Eur Respiratory Soc
external identifiers
  • wos:000179176500011
  • pmid:12449166
  • scopus:0036849465
ISSN
1399-3003
DOI
10.1183/09031936.02.00301702
language
English
LU publication?
yes
id
1a078872-a900-4929-93b8-fef3cd93d306 (old id 114693)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12449166&dopt=Abstract
date added to LUP
2007-07-02 14:55:19
date last changed
2017-10-29 03:36:36
@article{1a078872-a900-4929-93b8-fef3cd93d306,
  author       = {Wadbo, Monika and Löfdahl, Claes-Göran and Larsson, K and Skoogh, B E and Tornling, G and Arweström, E and Bengtsson, T and Ström, K},
  issn         = {1399-3003},
  keyword      = {Cholinergic Antagonists: adverse effects,Carbon Dioxide: blood,Chronic Obstructive: physiopathology,Quality of Life,Vital Capacity,Walking,Chronic Obstructive: drug therapy,Pulmonary Disease,Adrenergic beta-Agonists: adverse effects,Adrenergic beta-Agonists: therapeutic use,Adult,Aged,Bronchodilator Agents: adverse effects,Bronchodilator Agents: therapeutic use,Cholinergic Antagonists: therapeutic use,Comparative Study,Double-Blind Method,Dyspnea: etiology,Ethanolamines: adverse effects,Ethanolamines: therapeutic use,Female,Forced Expiratory Volume,Human,Ipratropium: adverse effects,Ipratropium: therapeutic use,Male,Middle Age,Oxygen: blood,Physical Endurance},
  language     = {eng},
  number       = {5},
  pages        = {1138--1146},
  publisher    = {Eur Respiratory Soc},
  series       = {European Respiratory Journal1988-01-01+01:00},
  title        = {Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.},
  url          = {http://dx.doi.org/10.1183/09031936.02.00301702},
  volume       = {20},
  year         = {2002},
}